Loading
journalsJournal
The breast journal
The Breast Journal is a US-founded journal on breast disease and breast cancer, now a fully open access Wiley title, read by breast surgeons, oncologists, radiologists and pathologists.
Also called: Breast JThe Breast Journal
Overview
The Breast Journal started in 1995 with Blackwell Science in Cambridge, Massachusetts; since 2022 the NLM Catalog records the Hindawi imprint of Wiley as publisher, and Crossref lists Hindawi Limited. NLM indexes it for MEDLINE under Breast Diseases and Breast Neoplasms, records it as bimonthly, and notes (from 2000 onward) that it is the official journal of the American Society of Breast Disease, the Senologic International Society and the International Society of Breast Pathology. DOAJ lists the journal as open access since 2022 with a CC BY licence, an article processing charge and anonymous peer review.
Publisher
Wiley (Hindawi)
Scope
breast cancer
Access model
open access
Founded
1995
ISSN
1075-122X
Similar pages
- JournalJournal of mammary gland biology and neoplasia
Shares Ductal carcinoma in situ (DCIS), PubMed & Europe PMC, HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- JournalBreast cancer
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalJournal of breast imaging
Shares Ductal carcinoma in situ (DCIS), PubMed & Europe PMC, HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- JournalThe Breast
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalClinical breast cancer
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalBreast cancer research
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- TermBreast implant-associated anaplastic large cell lymphoma
Shares Male breast cancer, HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- TermHow ER and PR are scored on a breast report (Allred score, H score, and why PR is not a UK core item)
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.